Literature DB >> 6134605

Reinforcements from the first drug experience can predict later drug habits and/or addiction: results with coffee, cigarettes, alcohol, barbiturates, minor and major tranquilizers, stimulants, marijuana, hallucinogens, heroin, opiates and cocaine.

C A Haertzen, T R Kocher, K Miyasato.   

Abstract

The relationship between the reinforcing quality of the first drug experiences and eventual habits for a variety of drugs was studied in 42 male drug abusers who were predominantly opiate addicts. These subjects volunteered for drug studies carried out by the Addiction Research Center. The degree of reinforcement they derived from their first drug experience was related to their subsequent habit. This was true for alcohol, barbiturates, minor tranquilizers, cocaine, stimulants, marijuana, glue or solvents, hallucinogens, opiates other than heroin and heroin. Positive but non-significant correlations were found for coffee and major tranquilizers. The correlation for cigarettes was contrary to expectations. Of the components to the index of reinforcement, degree of liking of a drug on the first occasion was most related to the subsequent habit. The greatest initial reinforcement scores were found for heroin, cocaine and opiates other than heroin. drugs which were not well liked on the first occasion included major tranquilizers, cigarettes, coffee, and glue.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134605     DOI: 10.1016/0376-8716(83)90076-5

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  56 in total

1.  Nicotine reinforcement in never-smokers.

Authors:  Angela N Duke; Matthew W Johnson; Chad J Reissig; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2015-09-08       Impact factor: 4.530

2.  Initial locomotor sensitivity to cocaine varies widely among inbred mouse strains.

Authors:  T Wiltshire; R B Ervin; H Duan; M A Bogue; W C Zamboni; S Cook; W Chung; F Zou; L M Tarantino
Journal:  Genes Brain Behav       Date:  2015-03       Impact factor: 3.449

3.  Adolescent rats are protected from the conditioned aversive properties of cocaine and lithium chloride.

Authors:  Nicole L Schramm-Sapyta; Richard W Morris; Cynthia M Kuhn
Journal:  Pharmacol Biochem Behav       Date:  2006-07-03       Impact factor: 3.533

4.  Assessment of the aversive and rewarding effects of alcohol in Fischer and Lewis rats.

Authors:  Peter G Roma; Wesley W Flint; J Dee Higley; Anthony L Riley
Journal:  Psychopharmacology (Berl)       Date:  2006-09-30       Impact factor: 4.530

Review 5.  Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Authors:  Colin N Haile; Thomas R Kosten; Therese A Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

6.  Aversion instead of preference learning indicated by nicotine place conditioning in rats.

Authors:  D E Jorenby; R E Steinpreis; J E Sherman; T B Baker
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

7.  Dose-dependent aversive and rewarding effects of amphetamine as revealed by a new place conditioning apparatus.

Authors:  S Cabib; S Puglisi-Allegra; C Genua; H Simon; M Le Moal; P V Piazza
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

8.  A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study.

Authors:  C J Spellicy; M J Harding; S C Hamon; J J Mahoney; J A Reyes; T R Kosten; T F Newton; R De La Garza; D A Nielsen
Journal:  Genes Brain Behav       Date:  2014-03-17       Impact factor: 3.449

9.  The amphetamine response moderates the relationship between negative emotionality and alcohol use.

Authors:  Kenneth J D Allen; Frances H Gabbay
Journal:  Alcohol Clin Exp Res       Date:  2012-12-14       Impact factor: 3.455

10.  Cocaine is low on the value ladder of rats: possible evidence for resilience to addiction.

Authors:  Lauriane Cantin; Magalie Lenoir; Eric Augier; Nathalie Vanhille; Sarah Dubreucq; Fuschia Serre; Caroline Vouillac; Serge H Ahmed
Journal:  PLoS One       Date:  2010-07-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.